How Small & Mid-Sized Drug Companies Can Implement an Effective Anti-Counterfeiting Strategy

Pharmaceutical counterfeiting presents a critical risk to patient safety and the franchise value of your growing enterprise. With so many points of attack and opportunity for illegitimate supply to comingle with genuine product, a company’s ability to detect, measure, and mitigate adverse events caused by fake products is the key to your own defense. Sometimes, establishing an anticounterfeiting program, or ACP, can seem daunting for companies in early commercial staging. However, leveraging key providers, their industry experience, and deploying proven technologies can be the best approach. “Investing in the latest security technologies is becoming an industry standard as government mandating bodies (only now) begin to require minimum levels of verification.”



Share content on email